Role of mitochondria in toxic oxidative stress

Molecular Interventions

Volumn 5, Issue 2, 2005, Pages 94-111

  Fariss, Marc W ^a,b   Chan, Catherine B ^c   Patel, Manisha ^a   Van Houten, Bennett ^d   Orrenius, Sten ^e  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^c UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACONITATE HYDRATASE; ACROLEIN; ALPHA TOCOPHEROL; ALPHA TOCOPHEROL DERIVATIVE; ALPHA TOCOPHEROL SUCCINATE; AMMONIUM SULFATE; ANTIOXIDANT; CARDIOLIPIN; CARMUSTINE; CYTOCHROME C; DOXORUBICIN; DRUG VEHICLE; FERROUS ION; FERROUS SULFATE; GLUTATHIONE PEROXIDASE; HYDROPEROXIDE; IONOPHORE; LACTATE DEHYDROGENASE; LIPID; MANGANESE SUPEROXIDE DISMUTASE; MESYLIC ACID ETHYL ESTER; MITOCHONDRIAL DNA; MITOCHONDRIAL ENZYME; MITOCHONDRIAL PROTEIN; OXYGEN; REACTIVE OXYGEN METABOLITE; ROTENONE; UNCOUPLING PROTEIN; UNCOUPLING PROTEIN 2; UNINDEXED DRUG;

APOPTOSIS; CELL PROTECTION; CYTOTOXICITY; DNA DAMAGE; ELECTRON TRANSPORT; HUMAN; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; NERVE DEGENERATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; REVIEW;

ACONITATE HYDRATASE; ANIMALS; CELL DEATH; CYTOCHROMES C; DIABETES MELLITUS, TYPE 2; DNA, MITOCHONDRIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; OXIDATIVE STRESS; OXYGEN; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; VITAMIN E;

EID: 17844403964     PISSN: 15340384     EISSN: None     Source Type: Journal    
DOI: 10.1124/mi.5.2.7     Document Type: Review

References (137)

1. Ischiropoulos, H. and Beckman, J.S. Oxidative stress and nitration in neurodegeneration: Cause, effect, or association? J. Clin. Invest. 111, 163-169 (2003).
2. Lenaz, G. The mitochondrial production of reactive oxygen species: Mechanisms and implications in human pathology. IUBMB Life 52, 159-164 (2001).
3. Green, D.R. and Kroemer, G. The pathophysiology of mitochondrial cell death. Science 305, 626-629 (2004).
4. Lemasters, J.J., Nieminen, A., Qian, T. et al. The mitochondrial permeability transition in cell death: A common mechanism in necrosis, apoptosis and autophagy. Biochim. Biophys. Acta 1366, 177-196 (1998).
5. Orrenius, S., Zhivotovsky, B., and Nicotera, P. Regulation of cell death: The calcium-apoptosis link. Nat. Rev. Mol. Cell Biol. 4, 552-565 (2003).
6. Napier, I., Ponka, P., and Richardson, D.R. Iron trafficking in the mitochondrion: Novel pathways revealed by disease. Blood, prepublished online November 4 (2004).
7. Petrosillo, G., Ruggiero, F.M., Pistolese, M., and Paradies, G. Calcium-induced reactive oxygen species production promotes cytochrome c release from rat liver mitochondria via mitochondrial permeability transition (MPT)-dependent and MPT-independent mechanisms. J. Biol. Chem. 279, 53103-53108 (2004).
8. Kishikawa, T., Edelstein, D., Du, X.L. et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemia damage. Nature 404, 787-790 (2000).
9. Enns, G.M. The contribution of mitochondria to common disorders. Mol. Genet. Metab. 80, 11-26 (2003).
10. Rouault, T.A. Hepatic iron overload in alcoholic liver disease: Why does it occur and what is its role in pathogenesis? Alcohol 30, 103-106 (2003).
11. Fariss, M.W. and Zhang, J.G. Vitamin E therapy in Parkinson's disease. Toxicology 189, 129-146 (2003).
12. Pessayre, D., Fromenty, B., and Mansouri, A. Mitochondrial injury in steatohepatitis. Eur. J. Gastroenterol. Hepatol. 16 , 1095-1105 (2004).
13. Nakagawa, Y. Mitochondria and neuroprotection: Role of mitochondrial phospholipid hydroperoxide gluthathione peroxidase (PHGPx) as an antiapoptotic factor. Biol. Pharm. Bull. 27, 956-960 (2004).
14. Muscoli, C., Cuzzocrea, S., Riley, D.P., Zweier, J.L., Thiemermann, C., Wang, Z., and Salvemini, D. On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies. Br. J. Pharmacol. 140, 445-460 (2003).
15. Ran, Q., Liang, H., Gu, M., Qi, W., Walter, C.A., Roberts II, L.J., Herman, B., Richardson, A., and Van Remmen, H. J. Transgenic mice overexpressing glutathione peroxidase 4 are protected against oxidative stress-induced apoptosis. J. Biol. Chem. 279, 55137-55146 (2004).
16. Liang, L. and Patel, M. Iron-sulfur enzyme mediated mitochondrial superoxide toxicity in experiential Parkinson's disease. J. Neurochem. 90, 1076-1084 (2004).
17. Smith, R.A.J., Kelso, G.F., Blaikie, F.H. et al. Using mitochondria-targeted molecules to study mitochondrial radical production and its consequences. Biochem. Soc. Trans. 31, 1295-1299 (2003).
18. Dhanasekaran, A., Kotamraju, S., Kalivendi, S.V. Matsunaga, T., Shang, T., Keszler, A., Joseph, J., and Kalyanaraman, B. Supplementation of endothelial cells with mitochondria-targeted antioxidants inhibit peroxide-induced mitochondrial iron uptake, oxidative damage, and apoptosis. J. Biol. Chem. 279, 37575-37587 (2004).
19. Zhao, K., Zhao, G., Wu, D., Soong, Y., Birk, A.V., Schiller, P.W., and Szeto H.H. Cell-permeable peptide antioxidant targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J. Biol. Chem. 279, 34682-34690 (2004).
20. Sukalski, K.A., Pinto, K.A., and Berntson, J.L. Decreased susceptibility of liver mitochondria from diabetic rats to oxidative damage and associated increase in α-tocopherol. Free Radic. Biol. Med. 14, 57-65 (1993).
21. Fariss, M.W., Nicholls-Grzemski, F.A., Tirmenstein, M.A., and Zhang, J.G. Enhanced antioxidant and cytoprotective abilities of vitamin E succinate is associated with a rapid uptake advantage in rat hepatocytes and mitochondria. Free Radic. Biol. Med. 31, 530-541 (2001).
22. Zhang. J. G., Nicholls-Grzemski, F.A., Tirmenstein, M.A. and Fariss, M.A. Vitamin E succinate protects hepatocytes against the toxic effect of reactive oxygen species generated at mitochondrial complexes I and III by alkylating agents. Chemico-Biol. Interact. 138, 267-284 (2001).
23. Tappel, A.L. Vitamin E as the biological lipid antioxidant. Vitam. Horm. 20, 493-510 (1962).
24. Burton, G.W., Joyce, A., and Ingold, K.U. Is vitamin E the only lipid-soluble, chain breaking antioxidant in human blood plasma and erythrocyte membranes? Arch. Biochem. Biophys. 221, 281-290 (1983).
25. Traber, M.G. Vitamin E in humans: Demand and delivery. Annu. Rev. Nutr. 16, 321-347 (1996).
26. Fariss, M.W. Anionic tocopherol esters as antioxidants and cytoprotectants, in Handbook of Synthetic Antioxidants (Packer, L., Cardenas, E. Eds.) pp 137-175, Marcel Dekker, New York (1997).
27. Kornburst, D.J., and Mavis, R.D. Relative susceptibility of microsomes from lung, heart, liver, kidney, brain, and testes to lipid peroxidation: Correlation with vitamin E content. Lipids 15, 315-322 (1980).
28. Fry, M., and Green, D.E. Cardiolipin requirements for electron transfer in Complex I and III of the mitochondrial respiratory chains. J. Biol. Chem. 256, 1874-1880 (1981).
29. Liebler, D.C., Kling, D.S., and Reed, D.J. Antioxidant protection of phospholipid bilayers by α-tocopherol. J. Biol. Chem. 261, 12114-12119 (1986).
30. Fariss, M.W. Pascoe, G.A., and Reed, D.J. Vitamin E reversal of the effect of extracellular calcium on chemically induced toxicity in hepatocytes. Science 227, 751-754 (1985).
31. Pascoe, G.A., and Reed, D.J. Vitamin E protection against chemical-induced cell injury. II. Evidence for the threshold effect of cellular α-tocopherol in prevention of adriamycin toxicity. Arch. Biochem. Biophys. 256, 159-166 (1987).
32. Carini, R., Giuseppe, P., Dianzani, M.U., Maddix, S.P., Slater, T.F., and Cheeseman, K.H. Comparative evaluation of activity of α-tocopherol, α-tocopherol polyethylene glycol 1000 succinate and α-tocopherol succinate in isolated hepatocytes and liver microsomal suspensions. Biochem. Pharmacol. 39, 1597-1601 (1990).
33. Fariss, M.W., Merson, M.H., and O'Hara, T.M. Alpha tocopherol succinate protects hepatocytes from chemical-induced toxicity under physiological calcium conditions. Toxicol. Lett. 47, 61-75 (1989).
34. Ray, S.D. and Fariss, M.W. Role of cellular energy status in tocopherol hemisuccinate cytoprotection against ethylmethanesulfonate-induced toxicity. Arch. Biochem. Biophy. 311, 180-190 (1994).
35. Blatt, D.H. Leonard, S.W., and Traber, M.G. Vitamin E kinetics and the function of tocopherol regulatory proteins. Nutrition 17, 799-805 (2001).
36. Kaempf-Rotzoll, D.E., Traber, M.G., and Arai, H. Vitamin E and transfer proteins. Curr. Opin. Lipidol. 14, 249-254 (2003).
37. Aruoma, O.I., Kaur, H., and Halliwell, B. Oxygen free radicals and human diseases. J. R. Soc. Health 111, 172-177 (1991).
38. Richardson, D.R. Friedreich's ataxia: Iron chelators that target the mitochondrion as a therapeutic strategy? Expert Opin. Investig. Drugs 12, 235-245 (2003).
39. Puccio, H., and Koenig, M. Friedreich ataxia: A paradigm for mitochondrial diseases. Curr. Opin. Genet. Dev. 12, 272-277 (2002).
40. Alper, G., and Narayanan, V. Friedreich's ataxia. Pediatr. Neurol. 28, 335-341 (2003).
41. Karthikeyan, K, Santos, J.H., Graziewicz, M.A., Copeland, W.C., Isaya, G., Van Houten, B., and Resnick, M.A. Reduction in frataxin causes progressive accumulation of mitochondrial damage. Hum. Mol. Genet. 12, 3331-3342. (2003).
42. Yakes, F.M., and Van Houten, B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 94 , 514-519 (1997).
43. Santos, J., Hunakova, L., Chen, Y., Bortner, C., and Van Houten, B. Cell-sorting experiments link persistent mitochondrial DNA damage with loss of mitochondrial membrane potential and apoptotic cell death. J. Biol. Chem. 278, 1728-1734 (2003).
44. Santos, J.H., Mandavilli, B.S., and Van Houten, B. Measuring oxidative mtDNA damage and repair using quantitative PCR. Methods Mol. Biol.197, 159-176 (2002).
45. Richter, C., Park, J.W., and Ames, B.N. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc. Natl. Acad. Sci. U. S. A. 85, 6465-6467 (1988).
46. Helbock, H.J., Beckman, K.B., Shigenaga, M.K., Walter, P.B., Woodall, A.A., Yeo, H.C., and Ames, B.N. DNA oxidation matters: The HPLC-electrochemical detection assay of 8-oxo-deoxyguanosine and 8-oxoguanine. Proc. Natl. Acad. Sci. U. S. A. 95, 288-293 (1998).
47. Santos, J.H., Meyer, J.N., Skorvaga, M., Annab, L.A., and Van Houten, B. Mitochondrial hTERT exacerbates free-radical-mediated mtDNA damage. Aging Cell. 3, 399-411 (2004).
48. Danial, N.N. and Korsmeyer, S.J. Cell death: Critical control points. Cell 116, 205-219 (2004).
49. Tuominen, E.K., Wallace, C.J., and Kinnunen, P.K. Phospholipid-cytochrome c interaction: Evidence for the extended lipid anchorage. J. Biol. Chem. 277, 8822-8826 (2002).
50. Iverson, S.L. and Orrenius, S. The cardiolipin-cytochrome c interaction and the mitochondrial regulation of apoptosis. Arch. Biochem. Biophys. 423, (2004) 37-46.
51. Ott, M., Robertson, J.D., Gogvadze, V., Zhivotovsky, B., and Orrenius, S. Cytochrome c release from mitochondria proceeds by a two-step process. Proc. Natl. Acad. Sci. U. S. A. 99, 1259-1263 (2002).
52. Shidoji, Y., Hayashi, K., Komura, S., Ohishi, N., and Yagi, K. Loss of molecular interaction between cytochrome c and cardiolipin due to lipid peroxidation, Biochem. Biophys. Res. Commun. 264, 343-347 (1999).
53. Paradies, G., Petrosillo, G., Pistolese, M., and Ruggiero, F.M. The effect of reactive oxygen species generated from the mitochondrial electron transport chain on the cytochrome c oxidase activity and on the cardiolipin content in bovine heart submitochondrial particles. FEBS Lett. 466, 323-326 (2000).
54. Ostrander, D.B., Sparagna, G.C., Amoscato, A.A., McMillin, J.B., and Dowhan, W. Decreased cardiolipin synthesis corresponds with cytochrome c release in palmitate-induced cardiomyocyte apoptosis. J. Biol. Chem. 276, 38061-38067 (2001).
55. Hardy, S., El-Assaad, W., Przybytkowski, E., Joly, E., Prentki, M., and Langelier, Y. Saturated fatty acid-induced apoptosis in MDA-MB-231 breast cancer cells. A role for cardiolipin. J. Biol. Chem. 278, 31861-31870 (2003).
56. Lutter, M., Fang, M., Luo, X., Nishijima, M., Xie, X., and Wang, X. Cardiolipin provides specificity for targeting of tBid to mitochondria. Nat. Cell Biol. 2, 754-761 (2000).
57. Kuwana, T., Mackey, M.R., Perkins, G., Ellisman, M.H., Latterich, M., Schneiter, R., Green, D.R., and Newmeyer, D.D. Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 111, 331-342 (2002).
58. Iverson, S.L., Enoksson, M., Gogvadze, V., Ott, M., and Orrenius, S. Cardiolipin is not required for Bax-mediated cytochrome c release from yeast mitochondria. J. Biol. Chem. 279, 1100-1107 (2004).
59. Zhong, L.T., Sarafian, T., Kane, D.J., Charles, A.C., Mah, S.P., Edwards, R.H., and Bredesen, D.E. Bcl-2 inhibits death of central neural cells induced by multiple agents. Proc. Natl. Acad. Sci. U. S. A. 90, 4533-4537 (1993).
60. Schulze-Osthoff, K., Bakker, A.C., Vanhaesebroeck, B., Beyaert, R., Jacob, W.A., and Fiers, W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J. Biol. Chem. 267, 5317-5323 (1992).
61. Manna, S.K., Zhang, H.J., Yan, T, Oberley, L.W., and Aggarwal, B.B. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoplosis and activation of nuclear transcription factor-kappaB and activated protein-1. J. Biol. Chem. 273, 13245-13254 (1998).
62. Nomura, K., Imai, H., Koumura, T., Kobayashi, T., and Nakagawa, Y. Mitochondrial phospholipid hydroperoxide glutathione peroxidase inhibits the release of cytochrome c from mitochondria by suppressing the peroxidation of cardiolipin in hypoglycaemia-induced apoptosis. Biochem. J. 351, 183-193 (2000).
63. Chen, Y., Cai, J., Murphy, T.J., and Jones, D.P. Overexpressed human mitochondrial thioredoxin confers resistance to oxidant-induced apoptosis in human osteosarcoma cells. J. Biol. Chem. 277, 33242-33248 (2002).
64. Chang, T.S., Cho, C.S., Park, S., Yu, S., Kang, S.W., and Rhee, S.G. Peroxiredoxin III, a mitochondrion-specific peroxidase, regulates apoptotic signaling by mitochondria. J. Biol. Chem. 279, 41975-41984 (2004).
65. Enoksson, M., Potamitou Fernandes, A., Prast, S., Lillig, C.H., Holmgren, A. and Orrenius, S. Overexpression of glutaredoxin 2 attenuates apoptosis by preventing cytochrome c release. Biochem. Biophys. Res. Commun. 327, 774-779 (2005).
66. Polyak, K., Xia, Y., Zweier, J.L., Kinzler, K.W., and Vogelstein, B. A model for p53-induced apoptosis. Nature 389, 300-305 (1997).
67. Atlante, A., Calissano, P., Bobba, A., Azzariti, A., Marra, E., and Passarella, S.Cytochrome c is released from mitochondria in a reactive oxygen species (ROS)-dependent fashion and can operate as a ROS scavenger and as a respiratory substrate in cerebellar neurons undergoing excitotoxic death. J. Biol. Chem. 275, 37159-37166 (2000).
68. Kirkland, R.A., Adibhatla, R.M., Hatcher, J.F., and Franklin, J.L. Loss of cardiolipin and mitochondria during programmed neuronal death: Evidence of a role for lipid peroxidation and autophagy. Neuroscience 115, 587-602 (2002).
69. Albers, D.S., Swerdlow, R.H., Manfredi, G., Gajewski, C., Yang, L., Parker, W.D., Jr., Beal, M.F. Further evidence for mitochondrial dysfunction in progressive supranuclear palsy. Exp. Neurol. 168, 196-198 (2001).
70. .-), superoxide dismutases, and related matters. J. Biol. Chem. 272, 18515-18517 (1997).
71. Boveris, A. and Chance, B. The mitochondrial generation of hydrogen peroxide. Biochem. J. 134, 707-716 (1973).
72. Gardner, P.R. Superoxide-driven aconitase Fe-S center cycling. Biosci. Res. 17, 33-42 (1997).
73. Flint, D.H., Tuminello, J.F., and Emptage, M.H. The inactivation of Fe-S cluster containing hydro-lyases by superoxide. J. Biol. Chem. 268, 22369-22376 (1993).
74. .-. Free Radic. Biol. Med. 26, 777-778 (1999).
75. Keyer, K. and Imlay, J.A. Superoxide accelerates DNA damage by elevating free-iron levels. Proc. Natl. Acad. Sci. U. S. A. 93, 13635-13640 (1996).
76. Vasquez-Vivar, J., Kalyanaraman, B., and Kennedy, M.C. Mitochondrial aconitase is a source of hydroxyl radical. An electron spin resonance investigation. J. Biol. Chem. 275, 14064-14069 (2000).
77. Beinert, H. and Kennedy, M. C. Aconitase, a two-faced protein:enzyme and iron regulatory factor. FASEB J. 7, 1442-1449 (1983).
78. Haile, D.J. Rouault, T.A., Harford, J.B., Kennedy, M.C., Blondin, G.A., and Klausner, R.D. Cellular regulation of the iron-responsive element binding protein: Disassembly of the cubane iron-sulfur cluster results in high afffinity RNA binding. Proc. Natl. Acad. Sci. U. S. A. 89, 11735-11739 (1992).
79. Rouault, T.A., Haile D.J., Downey, W.E. et al. An iron-sulfur cluster plays a novel regulatory role in the iron-responsive element binding protein. Biometals. 5, 131-140 (1992).
80. Kim, H.Y., LaVaute, T., Iwai, K., Klausner, R.D., and Rouault, T.A. Identification of a conserved and functional iron-responsive element in the 5′-untranslated region of mammalian mitochondrial aconitase. J. Biol. Chem. 271, 24226-24230 (1996).
81. Schalinske, K.L., Chen, O.S., and Eisenstein, R.S. Iron differentially stimulates translation of mitochondrial aconitase and ferritin mRNAs in mammalian cells. Implications for iron regulatory proteins as regulators of mitochondrial citrate utilization. J. Biol. Chem. 273, 3740-3746 (1998).
82. Liang, L.P., Ho, Y.S., and Patel, M. Mitochondrial superoxide production in kainate-induced hippocampal damage. Neuroscience 101, 563-570 (2000).
83. Schulz, J.B. and Beal, M.F. Mitochondrial dysfunction in movement disorders. Curr. Opin. Neurol. 7, 333-339 (1994).
84. Yan, L.J., Levine, R.L., and Sohal, R.S. Oxidative damage during aging targets mitochondrial aconitase. Proc. Natl. Acad. Sci. U. S. A. 94, 11168-11172 (1997).
85. Melov, S., Coskun, P., Patel M. et al. Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc. Natl. Acad. Sci. U. S. A. 96, 845-851 (1999).
86. Williams, M.D. Van Remmen, H., Conrad, C.C., Huang, T.T., Epstein, C.J., and Richardson, A. Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice. J. Biol. Chem. 273, 28510-28515 (1998).
87. -/+ mice. Free Radic. Biol. Med. 36, 542-554 (2004).
88. Sofic, E., Riederer, P., Heinsen, H., Beckmann, H., Reynolds, G.P., Hebernstreit, G., and Youdim, M.B. Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J. Neural Transm. 74, 199-205 (1988).
89. Kaur, D. Yantiri, F. Rajagopalan, S. et al. Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: A novel therapy for Parkinson's disease. Neuron 37, 899-909 (2003).
90. Betarbet, R., Sharer, T.B., Di Monte, D.A., and Greenamyre, J.T. Mechanistic approaches to Parkinson's disease pathogenesis. Brain Pathol. 12, 499-510 (2002).
91. Li, Q.Y., Pedersen, C., Day, B.J., and Patel, M. Dependence of excitotoxic neurodegeneration on mitochondrial aconitase inactivation. J. Neurochem. 78, 746-755 (2001).
92. Schapira, A.H., Cooper, J.M., Dexter, D., Jenner, P., Clark, J.B., and Marsden, C.D. Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1, 1269 (1989).
93. Dauer, W. and Przedborski, S. Parkinson's disease: Mechanisms and models. Neuron 39, 889-909 (2003).
94. Przedborski, S., Kostic, V., Jackson-Lewis, V., Naini, A.B., Simonetti, S., Fahn, S., Carlson, E., Epstein, C.J., and Cadet, J.L. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J. Neurosci. 12, 1658-1667 (1992).
95. Klivenyi, P., St. Clair, D., Warmer, M., Yen, H.C., Oberley, T., Yang, L., and Flint Beal, M. Manganese superoxide dismutase overexpression attenuates MPTP toxicity. Neurobiol. Dis. 5, 253-258 (1998).
96. Li, Y, Huang, T.T., Carlson, E.J. et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat. Genet. 11, 376-381 (1995).
97. Andreassen, O.A., Ferrante, R.J., Dedeoglu, A., Albers, D.W., Klivenyi, P., Carlson, E.J., Epstein, C.J., and Beal, M.F. Mice with a partial deficiency of manganese superoxide dismutase show increased vulnerability to the mitochondrial toxins malonate, 3-nitropropionic acid, and MPTP. Exp. Neurol. 167, 189-195 (2001).
98. Rouault, T.A. and Klausner, R.D. Iron-sulfur clusters as biosensors of oxidants and iron. Trends Biochem. Sci. 21, 174-177 (1996).
99. Tabrizi S.J., Cleeter, M.W., Xuereb J., Taanman J.W., Cooper J.M., and Schapira A.H. Biochemical abnormalities and excitotoxicity in Huntington's disease brain. Ann. Neurol. 45, 25-32 (1999).
100. Patel, M. Mitochondrial dysfunction and oxidative stress: Cause and consequence of epileptic seizures. Free Radic. Biol. Med. 37, 1951-1962 (2004).
101. O'Rahilly, S. Uncoupling protein 2: Adiposity angel and diabetes devil? Nature Med. 7, 770-772 (2001).
102. Bulotta, A., Ludovico, O., Coco, A., Di Paola, R., Quattrone, A., Carella, M., Pellegrini, F., Prudente, S., and Trischitta, V. The common -866G/A polymorphism in the promoter region of the UCP-2 gene is associated with reduced risk of type 2 diabetes in Caucasians from Italy. J. Clin. Endocrinol. Metab. 23, in press (2004).
103. D'Adamo, M., Perego, L., Cardellini, M. et al. The -866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes. Diabetes. 53, 1905-1910 (2004).
104. Sasahara, M., Nishi, M., Kawashima, H. et al. Uncoupling protein 2 promoter polymorphism -866G/A affects its expression in beta-cells and modulates clinical profiles of Japanese type 2 diabetic patients. Diabetes. 53, 482-485 (2004).
105. Wang, H., Chu W.S., Lu, T., Hasstedt, S.J., Kern, P.A., and Elbein, S.C. Uncoupling protein-2 polymorphisms in type 2 diabetes, obesity and insulin secretion. Am. J. Physiol. Endocrinol. Metab. 286, E1-E7 (2004).
106. Krempler, F., Esterbauer, H., Weitgasser, R. et al. A functional polymorphism in the promoter of UCP2 enhances obesity risk but reduces type 2 diabetes risk in obese middle-aged humans. Diabetes. 51, 3331-3335 (2002).
107. Astrup, A., Toubro, S., Dalgaard, L.T., Urhammer, S.A., Sorensen, T.I., and Pedersen, O. Impact of the v/v 55 polymorphism of the uncoupling protein 2 gene on 24-h energy expenditure and substrate oxidation. Int. J. Obes. Relat. Metab. Disord. 23, 1030-1034 (1999).
108. Urhammer, S.A., Dalgaard, L.T., Sorensen, T.I. et al. Mutational analysis of the coding region of the uncoupling protein 2 in obese NIDDM patients: Impact of a common amino acid polymorphism on juvenile and maturity onset forms of obesity and insulin resistance. Diabetologia 40, 1227-1230 (1997).
109. Kubota, T., Mori, H., Tamori, Y. et al. Molecular screening of uncoupling protein 2 gene in patients with noninsulin-dependent diabetes mellitus or obesity. J. Clin. Endocrinol. Metab. 83, 2800-2804 (2002).
110. Lameloise, N., Muzzin, P., Prentki, M., and Assimacopoulos-Jeannet, F. Uncoupling protein 2: A possible link between fatty acid excess and impaired glucose-induced insulin secretion? Diabetes 50, 803-809 (2001).
111. Joseph, J.W., Koshkin, V., Saleh, M.C., Sivitz, W.I., Zhang, C.-Y., Lowell, B.B., Chan, C.B., and Wheeler, M.B. Free fatty acid-induced β-cell defects are dependent on uncoupling protein 2 expression. J. Biol. Chem. 279, 51049-51056 (2004).
112. Poitout, V. and Robertson, R.P. Secondary beta-cell failure in type 2 diabetes-a convergence of glucotoxicity and lipotoxicity. Endocrinology 143, 339-342 (2002).
113. Antinozzi, P.A., Ishihara, H., Newgard, C.B., and Wollheim, C.B. Mitochondrial metabolism sets the maximal limit of fuel-stimulated insulin secretion in a model pancreatic beta cell. A survey of four fuel secretagogues. J. Biol. Chem. 277, 11746-11755 (2002).
114. Chan, C.B., MacDonald, P.E., Saleh, M.C., Johns, D.C., Marban, E., and Wheeler, M.B. Overexpression of uncoupling protein 2 inhibits glucose stimulated insulin secretion from rat islets. Diabetes 48, 1482-1486 (1999).
115. Chan, C.B., De Leo, D., Joseph, J.W. et al. Increased uncoupling protein-2 levels in β-cells are associated with impaired glucose-stimulated insulin secretion: Mechanism of action. Diabetes . 50, 1302-1310 (2001).
116. Hong, Y., Fink, B.D., Dillon, J.S., and Sivitz, W.I. Effects of adenoviral overexpression of uncoupling protein-2 and -3 on mitochondrial respiration in insulinoma cells. Endocrinology 142 , 249-256 (2001).
117. Zhang, C.-Y., Baffy, G., Perret, P. et al. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, β-cell dysfunction, and type 2 diabetes. Cell 105, 745-755 (2001).
118. Kassis, N., Bernard, C., Pusterla, A., Cateilla, L., Penicaud, L., Richard, D., Ricquier, D., and Ktorza, A. Correlation between pancreatic islet uncoupling protein-2 (UCP2) mRNA concentration and insulin status in rats. Int. J. Exp. Diabetes Res. 1, 185-193 (2000).
119. Laybutt, D.R., Sharma, A., Sgroi, D.C., Gaudet, J., Bonner-Weir, S., and Weir, G.C. Genetic regulation of metabolic pathways in beta-cells disrupted by hyperglycemia. J. Biol. Chem. 277, 10912-10921 (2002).
120. Joseph, J.W., Koshkin, V., Zhang, C.-Y., Wang, J., Lowell, B.B., Chan, C.B., and Wheeler, M.B. Uncoupling protein 2 knockout mice have enhanced insulin secretory capacity after high-fat diet. Diabetes 51, 3211-3219 (2002).
121. Tordjman, K., Standley, K.N., Bernal-Mizrachi, C., Leone, T.C., Coleman, T., Kelly, D.P., and Semenkovich, C.F. PPARα suppresses insulin secretion and induces UCP2 in insulinoma cells. J. Lipid Res. 43, 936-943 (2002).
122. Patane, G., Anello, M., Piro, S., Vigneri, R., Purrello, F., and Rabuazzo, A.M. Role of ATP production and uncoupling protein-2 in the insulin secretory defect induced by chronic exposure to high glucose or free fatty acids and effects of peroxisome proliferator-activated receptor-γ inhibition. Diabetes 51, 2749-2756 (2002).
123. Medvedev, A.V., Robidoux, J., Bai, X., Cao, W., Floering, L.M., Daniel, K.W., and Collins, S. Regulation of the uncoupling protein-2 gene in INS-1 β-cells by oleic acid. J. Biol. Chem. 277, 42639-42644 (2002).
124. Krauss, S., Zhang, C.-Y., Scorrano, L., Dalgaard, L.T., St.-Pierre, J., Grey, S.T., and Lowell, B.B. Superoxide-mediated activation of uncoupling protein 2 causes pancreatic β cell dysfunction. J. Clin. Invest. 112, 1831-1842 (2003).
125. Chan, C.B., Saleh, M.C., Koshkin, V., and Wheeler, M.B. Uncoupling protein 2 and islet function. Diabetes 53 (Suppl. 1), S136-S142 (2004).
126. Li, L.-X., Skorpen, F., Egeberg, K., Jorgenssen, I.H., and Grill, V. Uncoupling protein-2 participates in cellular defense against oxidative stress in clonal β-cells. Biochem. Biophys. Res. Commun. 282, 273-277 (2001).
127. Carlsson, C., Borg, L.A., and Welsh, N. Sodium palmitate induces partial mitochondrial uncoupling and reactive oxygen species in rat pancreatic islets in vitro. Endocrinology 140, 3422-3428 (1999).
128. Wang, X., Li, H., De Leo, D. et al. Gene and protein kinase expression profiling of reactive oxygen species-associated lipotoxicity in the pancreatic β-cell line MIN6. Diabetes 53, 129-140 (2004).
129. Maestre, I., Jordan, J., Calvo, S., Reig, J.A., Cena, V., Soria, B., Prentki, M., and Roche, E. Mitochondrial dysfunction is involved in apoptosis induced by serum withdrawal and fatty acids in the beta-cell line INS-1. Endocrinology 144, 335-345 (2003).
130. Moore, P.C., Ugas, M.A., Hagman, D.K., Parazzoli, S.D., and Poitout, V. Evidence against the involvement of oxidative stress in fatty acid inhibition of insulin secretion. Diabetes 53, 2610-2616 (2004).
131. Li, L.-X., Skorpen, F., Egeberg, K., Jorgensen, I.H., and Grill, V. Induction of uncoupling protein 2 mRNA in β-cells is stimulated by oxidation of fatty acids but not by nutrient oversupply. Endocrinology 143, 1371-1377 (2002).
132. Koshkin, V., Wang, X., Scherer, P.E., Chan, C.B., and Wheeler, M.B. Mitochondrial functional state in clonal pancreatic β-cells exposed to free fatty acids. J. Biol. Chem. 278, 19709-19715 (2003).
133. Robertson, R.P., Harmon, J., Tran, P.O., Tanaka, Y., and Takahashi, H. Glucose toxicity in β-cells: Type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes 52 , 581-587 (2003).
134. Echtay, K.S., Murphy, M.P., Smith, R.A., Talbot, D.A., and Brand, M.D. Superoxide activates mitochondrial uncoupling protein 2 from the matrix side. Studies using targeted antioxidants. J. Biol. Chem. 277, 47129-47135 (2002).
135. Murphy, M.P., Echtay, K.S., Blaikie, F.H. et al. Superoxide activates uncoupling proteins by generating carbon-centered radicals and initiating lipid peroxidation: Studies using a mitochondria-targeted spin trap derived from alpha-phenyl-N-tert-butylnitrone. J. Biol. Chem. 278, 48534-48545 (2003).
136. Goglia, F. and Skulachev, V.P. A function for novel uncoupling proteins: Antioxidant defense of mitochondrial matrix by translocating fatty acid peroxides from the inner to the outer membrane leaflet. FASEB J. 17, 1585-1591 (2003).
137. Double, K. L., Geriach, M., Youdim, M. B., and Riederer, P. Impaired iron homeostasis in Parkinson's disease. J. Neural Transm. Suppl. (60), 37-58 (2000).